Literature DB >> 33085908

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.

Filippo Sanfilippo1, Valeria La Rosa2, Francesco Oliveri1, Marinella Astuto1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33085908     DOI： 10.1164/rccm.202008-3139LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

1.  A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.

Authors:  Max R O'Donnell; Beatriz Grinsztejn; Matthew J Cummings; Jessica E Justman; Matthew R Lamb; Christina M Eckhardt; Neena M Philip; Ying Kuen Cheung; Vinay Gupta; Esau João; Jose Henrique Pilotto; Maria Pia Diniz; Sandra Wagner Cardoso; Darryl Abrams; Kartik N Rajagopalan; Sarah E Borden; Allison Wolf; Leon Claude Sidi; Alexandre Vizzoni; Valdilea G Veloso; Zachary C Bitan; Dawn E Scotto; Benjamin J Meyer; Samuel D Jacobson; Alex Kantor; Nischay Mishra; Lokendra V Chauhan; Elizabeth F Stone; Flavia Dei Zotti; Francesca La Carpia; Krystalyn E Hudson; Stephen A Ferrara; Joseph Schwartz; Brie A Stotler; Wen-Hsuan W Lin; Sandeep N Wontakal; Beth Shaz; Thomas Briese; Eldad A Hod; Steven L Spitalnik; Andrew Eisenberger; Walter I Lipkin
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

2.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.